Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
Primary Purpose
Behavior
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Behavioral interventions/modifications
Sponsored by

About this trial
This is an interventional other trial for Behavior focused on measuring weight loss, weight maintenance
Eligibility Criteria
Inclusion Criteria:
- Male or female aged 18 yrs or older
- BMI >40 kg/m2
- BMI between 35-40 kg/m2 with obesity-related co-morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia. Type 2 Diabetes Mellitus defined by A1c >6.4% with or without oral hypoglycemic agents and with or without insulin therapy. Hypertension defined by blood pressure >140/80 mm of hg with or without antihypertensive therapy. Dyslipidemia defined as fasting lipid profile with one or more of the following abnormalities: serum cholesterol levels >200 mg/dl, serum triglyceride levels >150 mg/dl, HDL levels <50 mg/dl, LDL levels >100 mg/dl with or without therapy.
Exclusion Criteria:
- Binge eating disorder (Bulemia, Anorexia nervosa)
- Congestive heart failure NYHA Class >3
- >Stage 3 chronic kidney disease
- Cardiovascular disease (non-fatal MI, non-fatal stroke, peripheral vascular disease) within the past 6 months of screening
- Planned coronary artery, carotid artery or peripheral artery revascularization
- Weight loss surgery (gastric bypass, sleeve gastrectomy, total/subtotal gastrectomy) within the past 2 yrs.
- Pregnant and lactating females
- Active malignancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
OPTIFAST only
UPMC PFW followed by OPTIFAST
Arm Description
Control group will consist of participants that have not undergone behavioral modifications with the Prescription for Wellness Program. These are participants that only go through the OPTIFAST Program.
The intervention group will consist of participants that have undergone behavioral modifications with the Prescription for Wellness Program. These are participants who undergo the Prescription for Wellness Program prior to the OPTIFAST Program.
Outcomes
Primary Outcome Measures
Change from baseline in body weight at 6 months
The degree of weight loss in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
Change from 6 months in body weight at 18 months
The duration of weight maintenance in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
Secondary Outcome Measures
Change from baseline in blood pressure at 18 months
change in blood pressure over time in participants who undergo behavioral interventions compared to those who do not.
Change from baseline in A1c at 18 months
change in A1c over time in participants who undergo behavioral interventions compared to those who do not.
Change from baseline in lipid profile at 18 months
change in lipid profile overtime in participants who undergo behavioral interventions compared to those who do not.
Change from baseline in medication burden (number of medications) at 18 months
Change in medication burden (number of medications) pertaining to type 2 DM and hypertension over time
Change from baseline in medication burden (dose of medications) at 18 months
Change in medication burden (dose of medications) pertaining to type 2 DM and hypertension over time
Full Information
NCT ID
NCT04190069
First Posted
December 4, 2019
Last Updated
June 22, 2020
Sponsor
University of Pittsburgh
1. Study Identification
Unique Protocol Identification Number
NCT04190069
Brief Title
Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
Official Title
Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Withdrawn
Why Stopped
IRB recommended change to registry study or quality improvement project status
Study Start Date
January 2020 (Anticipated)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
December 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of the study is to examine the extent to which diet/lifestyle change programs with a multidisciplinary team (consisting of a dietician, physician and behaviorist/health coach) that develop healthy behaviors before creating a calorie deficit for weight loss will result in greater weight loss and a longer duration of weight maintenance. It intends to compare the extent of weight loss and weight maintenance in participants who will undergo calorie restriction without prior behavioral interventions to participants that will undergo behavioral interventions prior to starting calorie restriction.
Detailed Description
OPTIFAST is a medically supervised weight loss and weight management program that involves a complete meal replacement followed by a gradual introduction of foods after dietary education. The resources offered through this program are through a physician, registered dietitian and behaviorist, including a psychologist.
UPMC Prescription for Wellness is an innovative physician/provider prescribed coaching and feedback program that improves patient engagement and outcomes in healthy behaviors; self-care of chronic disease and condition management; and shared decision-making. The resources available through this program are offered via a telephonic health coach, online or through a digital intervention based on the participant's convenience.
The objective of the study is to examine the extent to which diet/lifestyle change programs with a multidisciplinary team (consisting of a dietician, physician and behaviorist/health coach) that develop healthy behaviors before creating a calorie deficit for weight loss will result in greater weight loss and a longer duration of weight maintenance. It intends to compare the extent of weight loss and weight maintenance in participants who will undergo calorie restriction without prior behavioral interventions to participants that will undergo behavioral interventions prior to starting calorie restriction.
Behavioral interventions will first be provided by UPMC Prescription for Wellness prior to starting OPTIFAST. Calorie restriction will be during the OPTIFAST Program. The participants will be actively recruited by the study team at the Center for Diabetes and Metabolism (CDE) at the Falk Clinic in Oakland, Pittsburgh.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Behavior
Keywords
weight loss, weight maintenance
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
OPTIFAST only
Arm Type
No Intervention
Arm Description
Control group will consist of participants that have not undergone behavioral modifications with the Prescription for Wellness Program. These are participants that only go through the OPTIFAST Program.
Arm Title
UPMC PFW followed by OPTIFAST
Arm Type
Experimental
Arm Description
The intervention group will consist of participants that have undergone behavioral modifications with the Prescription for Wellness Program. These are participants who undergo the Prescription for Wellness Program prior to the OPTIFAST Program.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral interventions/modifications
Intervention Description
UPMC Prescription for Wellness is an innovative physician/provider prescribed coaching and feedback program that improves patient engagement and outcomes in healthy behaviors; self-care of chronic disease and condition management; and shared decision-making. The resources available through this program are offered via a telephonic health coach, online or through a digital intervention based on the participant's convenience.
Primary Outcome Measure Information:
Title
Change from baseline in body weight at 6 months
Description
The degree of weight loss in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
Time Frame
6 months
Title
Change from 6 months in body weight at 18 months
Description
The duration of weight maintenance in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
Time Frame
6 months vs 18 months
Secondary Outcome Measure Information:
Title
Change from baseline in blood pressure at 18 months
Description
change in blood pressure over time in participants who undergo behavioral interventions compared to those who do not.
Time Frame
18 months
Title
Change from baseline in A1c at 18 months
Description
change in A1c over time in participants who undergo behavioral interventions compared to those who do not.
Time Frame
18 months
Title
Change from baseline in lipid profile at 18 months
Description
change in lipid profile overtime in participants who undergo behavioral interventions compared to those who do not.
Time Frame
18 months
Title
Change from baseline in medication burden (number of medications) at 18 months
Description
Change in medication burden (number of medications) pertaining to type 2 DM and hypertension over time
Time Frame
18 months
Title
Change from baseline in medication burden (dose of medications) at 18 months
Description
Change in medication burden (dose of medications) pertaining to type 2 DM and hypertension over time
Time Frame
18 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male or female aged 18 yrs or older
BMI >40 kg/m2
BMI between 35-40 kg/m2 with obesity-related co-morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia. Type 2 Diabetes Mellitus defined by A1c >6.4% with or without oral hypoglycemic agents and with or without insulin therapy. Hypertension defined by blood pressure >140/80 mm of hg with or without antihypertensive therapy. Dyslipidemia defined as fasting lipid profile with one or more of the following abnormalities: serum cholesterol levels >200 mg/dl, serum triglyceride levels >150 mg/dl, HDL levels <50 mg/dl, LDL levels >100 mg/dl with or without therapy.
Exclusion Criteria:
Binge eating disorder (Bulemia, Anorexia nervosa)
Congestive heart failure NYHA Class >3
>Stage 3 chronic kidney disease
Cardiovascular disease (non-fatal MI, non-fatal stroke, peripheral vascular disease) within the past 6 months of screening
Planned coronary artery, carotid artery or peripheral artery revascularization
Weight loss surgery (gastric bypass, sleeve gastrectomy, total/subtotal gastrectomy) within the past 2 yrs.
Pregnant and lactating females
Active malignancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Rometo, M.D
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
We'll reach out to this number within 24 hrs